The latest news comes next year or a new round of adjustment of the base drug catalog.

In fact, as early as May, the relevant departments in 2020 work points will clearly start the adjustment of the base drug catalog in due course. In explaining part of the basic drug system, the
document mentions, "National Research and Evaluation of the implementation of the 2018 edition of the National Essential Medicines Directory, collection and analysis of the use of medicines at all levels of medical institutions."
study and revise the national basic drug catalogue management methods, optimize the selection and adjustment procedures for the catalogue, and start the catalog adjustment work in due course".
The Law of the People's Republic of China on the Promotion of Basic Medical and Health Care, which came into effect on June 1 this year, also mentions in the drug supply guarantee section that the State implements the basic drug system and dynamically adjusts the list of essential drugs in accordance with the clinical practice of drugs, changes in drug standards and new drug listings.
According to the Opinions on Improving the National Basic Drug System issued by the General Office of the State Council on September 19, 2018, the adjustment period of the list of essential medicines shall not exceed three years in principle.
at the 2018 edition of the list of basic drugs released, the National Health and Care Commission further said that the next step will be to implement the "Opinion" requirements, as soon as possible to revise and improve the "National Basic Drug Catalog Management Measures."
as we all know, the base drug catalog management method is to carry out the base drug catalog adjustment of the guiding document, that is, the revision of the base drug catalog management method big probability is for the new version of the base drug catalog adjustment paving the way, in accordance with the base drug catalog 3-year cycle of dynamic adjustment principle, next year the base drug catalog ushered in a new round of adjustment is a big probability event.
according to information provided by people familiar with the situation, the recent meeting around the base drug information points are as follows: 1. This year will be issued based on the management of the drug, in the 2015 version of the basis of the revision of 2. After the introduction of the management measures will be based on the management methods to develop a specific base drug adjustment program, is not expected to start this year.
3. The adjustment cycle of the base drug remains unchanged for 3 years and may be adjusted dynamically every year.
4. The positioning of the base drug remains unchanged, or according to the requirements of the base drug system No. 88, the classification of the base drug, the selection process and experts are not specifically discussed.
5. No mention was made of the 1 plus x requirement.
6. It is recommended that the base drug be combined with the chronic long prescription policy, and that the state design from the top level to develop a catalogue of core drug use for the base drug.
clinical comprehensive evaluation, encourage trade associations, scientific research institutions, production enterprises, medical institutions, social organizations and other active evidence-based medical research, clinical medical evaluation.
catalog management methods clear basic drug adjustment rules On August 18, 2009, the former Ministry of Health jointly 9 ministries issued the "Implementation Opinionon on the Establishment of the National Basic Drug System", marking the formal implementation of China's national basic drug system.
in the second half of 2014, the former National Health and Planning Commission began to evaluate and investigate the basic drug catalogue, combined with the relevant experience of the drug catalog management method in the medical reform over the past five years, put forward some amendments, forming the 2015 version of the basic drug catalog management method.
According to the former Health and Planning Commission, the management method of the base medicine catalogue should become a long-term institutional arrangement, and further improve the selection mechanism of basic drugs.
April 14, 2015, the former State Health and Planning Commission issued a "Notice on the Administration of the Administration of the National Basic Drug Catalog", and the management measures for the catalogue of basic drugs entered the stage of the long-term system from the provisional one, and were formally implemented on the date of its issuance.
based on the management of the base drug catalogue at different times, china's base drug catalogue has been adjusted three times - the most recent adjustment of the base drug catalog is 2018.
October 25, 2018, the National Health and Health Commission issued the Notice on the Issue of the National Essential Medicines Catalog (2018 Edition), with 685 varieties shortlisted, and the new version of the base drug catalogue will come into effect on November 1, 2018.
in the "National Basic Medicines Catalog (2018 edition) interpretation", the National Health and Health Commission specifically stressed the need to improve the catalog adjustment management mechanism, the catalog regularly carried out assessment, the implementation of dynamic adjustment, adjustment cycle in principle not more than 3 years;
in accordance with the requirements of the current "National Basic Drug Catalog Management Measures", the adjustment of the base drug catalog mainly refers to the World Health Organization's basic drug catalogue and the relevant national (regional) drug roster selection procedures and principles, according to China's disease spectrum and drug use characteristics, fully consider the current basic national conditions and security capabilities, sum up the previous catalog formulation and adjustment of practical experience to clearly transfer in and out of the basic drug catalog standards.
the standard of drug transfer and transfer of the current list of basic drugs: First, combined with the disease spectrum, morbidity, disease burden, etc., to meet common diseases, chronic diseases and heavy burden, harmful diseases and critical and serious, public health and other basic drug needs, from the drugs already listed in China, select the appropriate quantity of essential drugs.
is to support the development of Chinese medicine, support the development and innovation of the pharmaceutical industry, to Chinese medicine (including ethnic medicine), domestic innovative medicine tilt.
the Opinions of the General Office of the State Council on Improving the National Basic Drug System also calls for strengthening evidence-based decision-making and highlighting the clinical value of medicines.
specification dosage form specifications, can orally doosine injection, can muscle injection does not infusion.
support the development of Chinese medicine and encourage research and development and innovation in the pharmaceutical industry.
the transfer process may be initiated in due course if the newly approved and listed drugs have significantly improved their efficacy and are reasonably priced.
the criteria for drug transfer: First, the drug standard was replaced; second, the State Drug Administration revoked its drug approval documents; third, adverse reactions, assessed as not suitable for use as national essential drugs; fourth, according to the evaluation of drug economics, can be replaced by the risk-benefit ratio or cost-effective varieties; and fifth, the National Basic Medicines Working Committee should be transferred to other circumstances.
in addition, the Opinions of the General Office of the State Council on the Improvement of the National Basic Drug System require that the focus be on the transfer of drugs that have been withdrawn from the market, which have occurred more serious adverse reactions, which have been assessed as not suitable for essential drugs, and which have a risk-benefit ratio or better cost-effective ness to replace the drugs.
in principle, no medicines are added to all places, and minority areas may add a small number of ethnic medicines. although
, the management method of the base medicine catalog will be further adjusted and optimized, but it is undeniable that the current standard of transfer-out as stipulated in the management method of the base medicine catalog still has some reference and reference significance for the adjustment of the base medicine catalog.
after all, since 2009, the main content of the management of the basic medicine catalog management method simply does not change greatly, it can be seen that some of these standards still stand the test of time.
policy has repeatedly strengthened the provision and use of basic drugs In accordance with the "Opinion of the General Office of the State Council on further doing a good job in the work of maintaining and stabilizing the price of shortage drugs", to promote the priority use of essential drugs and rational use of drugs.
"promote the priority use of basic drugs, enhance the proportion of basic drug use, and timely adjust the national list of basic drugs, and gradually realize the government-run primary health care institutions, secondary public hospitals, tertiary public hospitals, the proportion of basic drugs equipped with varieties in principle is not less than 90%, 80%, 60%, and promote medical institutions at all levels to form a basic drugs-led "1 plus X" ("1" for the national basic drug catalogue, "X" for non-essential drugs, by the actual determination of the use of drug patterns.
in addition, the National Health and Care Commission has requested local governments to carry out comprehensive pilot projects on the basic drug system, encourage urban medical groups and county medical community to establish a unified drug catalogue and supply guarantee mechanism, and promote the convergence of drug use among medical institutions at the upper and lower levels.
According to Seiber Blue, many provinces have followed up the release of the 986 policy for the use of base medicine.
in accordance with the Opinions of the General Office of the State Council on the Improvement of the National Basic Drug System, the new version of the National Basic Drug Catalog has been published, and there should be no additional drugs in principle, that is, the path to entry into the list of essential drugs from local channels has been blocked.
at the same time, many departments have issued a number of articles to enhance the use of essential drugs, asking for an increase in the proportion of basic drug use.
based on this, a new round of national base drug catalog adjustment is undoubtedly a major industry event.
follow-up with the introduction of the 2020 version of the base drug catalog management methods, 2021 will be adjusted to the base drug catalog, will be further clear.
original title: News coming out! The base medicine catalogue will be adjusted.